Incidence and distribution of HER2-positive gastric and gastroesophageal junction (GEJ) adenocarinomas in British Columbia (BC)

被引：0
|
作者：
Lim, H. J.
Aubin, F.
Kollmannsberger, C. K.
Huntsman, D.
Carter, B.
Zhou, C.
Woods, R.
Gill, S.
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[2] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[3] British Columbia Canc Agcy, Vancouver Canc Ctr, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.91
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
91
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study
    Sawaki, Akira
    Ohashi, Yasuo
    Omuro, Yasushi
    Satoh, Taroh
    Hamamoto, Yasuo
    Boku, Narikazu
    Miyata, Yoshinori
    Takiuchi, Hiroya
    Yamaguchi, Kensei
    Sasaki, Yasutsuna
    Nishina, Tomohiro
    Satoh, Atsushi
    Baba, Eishi
    Tamura, Takao
    Abe, Takashi
    Hatake, Kiyohiko
    Ohtsu, Atsushi
    GASTRIC CANCER, 2012, 15 (03) : 313 - 322
  • [32] Phase 2 study of trastuzumab deruxtecan in the neoadjuvant treatment for patients with HER2-positive gastric and gastroesophageal junction adenocarcinoma (EPOC2003)
    Takahari, Daisuke
    Kawazoe, Akihito
    Machida, Nozomu
    Minashi, Keiko
    Yamagata, Yukinori
    Hara, Hiroki
    Wakabayashi, Masashi
    Komura, Yu
    Sato, Akihiro
    Kuwata, Takeshi
    Kojima, Motohiro
    Shitara, Kohei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study
    Akira Sawaki
    Yasuo Ohashi
    Yasushi Omuro
    Taroh Satoh
    Yasuo Hamamoto
    Narikazu Boku
    Yoshinori Miyata
    Hiroya Takiuchi
    Kensei Yamaguchi
    Yasutsuna Sasaki
    Tomohiro Nishina
    Atsushi Satoh
    Eishi Baba
    Takao Tamura
    Takashi Abe
    Kiyohiko Hatake
    Atsushi Ohtsu
    Gastric Cancer, 2012, 15 : 313 - 322
  • [34] The impact of HER2 positivity on survival in metastatic gastric and GEJ cancer in the province of British Columbia: An updated analysis
    Lim, Howard John
    Kumar, Aalok
    Zhou, Chen
    Huntsman, David
    Kollmannsberger, Christian K.
    Gill, Sharlene
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Pembrolizumab in HER2-Positive Gastric Cancer
    Janjigian, Yelena Y.
    Kawazoe, Akihito
    Bai, Yuxian
    Xu, Jianming
    Lonardi, Sara
    Metges, Jean Phillipe
    Yanez, Patricio
    Wyrwicz, Lucjan S.
    Shen, Lin
    Ostapenko, Yuriy
    Bilici, Mehmet
    Chung, Hyun Cheol
    Shitara, Kohei
    Qin, Shukui
    Van Cutsem, Eric
    Tabernero, Josep
    Luo, Suxia
    Mahave, Mauricio
    Tang, Yong
    Lowery, Maeve
    Monteiro, Maria M. F.
    Xu, Linzhi
    Shih, Chie-Schin
    Sharan, Kanu P.
    Bhagia, Pooja
    Rha, Sun Young
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (14): : 1360 - 1362
  • [36] Pembrolizumab in HER2-Positive Gastric Cancer
    Janjigian, Yelena Y.
    Kawazoe, Akihito
    Bai, Yuxian
    Xu, Jianming
    Lonardi, Sara
    Metges, Jean Phillipe
    Yanez, Patricio
    Wyrwicz, Lucjan S.
    Shen, Lin
    Ostapenko, Yuriy
    Bilici, Mehmet
    Chung, Hyun Cheol
    Shitara, Kohei
    Qin, Shukui
    Van Cutsem, Eric
    Tabernero, Josep
    Luo, Suxia
    Mahave, Mauricio
    Tang, Yong
    Lowery, Maeve
    Monteiro, Maria M. F.
    Xu, Linzhi
    Shih, Chie-Schin
    Sharan, Kanu P.
    Bhagia, Pooja
    Rha, Sun Young
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [37] Central nervous system relapse in patients with untreated HER2-positive esophageal or gastroesophageal junction adenocarcinoma
    Yoon, Harry H.
    Lewis, Mark A.
    Foster, Nathan R.
    Sukov, William R.
    Khan, Maliha
    Sattler, Christopher A.
    Wiktor, Anne E.
    Wu, Tsung-Teh
    Jenkins, Robert B.
    Sinicrope, Frank A.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (07) : 1626 - 1631
  • [38] HER 2 Expression in Gastric and Gastro-esophageal Junction (GEJ) Adenocarcinomas
    Rajagopal, Indu
    Niveditha, S. R.
    Sahadev, R.
    Nagappa, Preethan Kamagere
    Rajendra, Sowmya Goddanakoppal
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (03) : EC06 - EC10
  • [39] Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer
    Gravalos, Cristina
    Gomez-Martin, Carlos
    Rivera, Fernando
    Ales, Inmaculada
    Queralt, Bernardo
    Marquez, Antonia
    Jimenez, Ulpiano
    Alonso, Vicente
    Garcia-Carbonero, Rocio
    Sastre, Javier
    Colomer, Ramon
    Cortes-Funes, Hernan
    Jimeno, Antonio
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (03): : 179 - 184
  • [40] Clinical outcomes of radical gastrectomy following trastuzumab-based chemotherapy for stage IV HER2-positive gastric or gastroesophageal junction cancer
    Ryo Takahashi
    Souya Nunobe
    Hiroki Osumi
    Daisuke Takahari
    Noriko Yamamoto
    Satoshi Ida
    Koshi Kumagai
    Manabu Ohashi
    Takeshi Sano
    Naoki Hiki
    Surgery Today, 2020, 50 : 1240 - 1248
12345